Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis

Thorax

Volumn 57, Issue 5, 2002, Pages 446-448

  Thompson, Catherine S ^a   Harrison, S ^a   Ashley, J ^a   Day, K ^a   Smith, D L ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AIRWAY; ARTICLE; BREATHING PATTERN; BRONCHIECTASIS; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; FEMALE; HUMAN; MALE; MEDICAL INSTRUMENTATION; PHYSIOTHERAPY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; TREATMENT OUTCOME;

BRONCHIECTASIS; CROSS-OVER STUDIES; EQUIPMENT DESIGN; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PHYSICAL THERAPY MODALITIES; POSITIVE-PRESSURE RESPIRATION; VITAL CAPACITY;

EID: 0036261083     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.5.446     Document Type: Article

References (15)

1. The Flutter VRP1 valve as an adjunct to chest physiotherapy in cystic fibrosis
2. Comparison of Flutter device and chest physical therapy in the treatment of cystic fibrosis pulmonary exacerbation
3. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis
4. Comparison of the Flutter device to standard chest physiotherapy in hospitalized patients with cystic fibrosis. A pilot study
5. The value of physical therapy with VRP1-Destin
6. Long-term comparative trial of positive expiratory pressure versus positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis
7. Chest physical therapy in patients with an acute excerbation of chronic bronchitis: Effectiveness of three methods
8. Clinical evaluation of oscillating positive expiratory pressure for enhancing expectoration in diseases other than cystic fibrosis
9. Physiotherapy with the VRP1 for chronic obstructive pulmonary diseases: Results of a multicenter comparative study
10. The Flutter VRP1: A new personal pocket therapeutic device used as a adjunct to drug therapy in the management of branchial asthma
11. Use of flutter VRP1 in the management of patients with steriod-dependant asthma
12. Clinical efficacy of the Flutter device for airway mucus clearance in patients with diffuse panbronchiolitis
13. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy. Flutter vs autogenic drainage
14. Sodium chloride increases the transportability of cystic fibrosis and bronchiectasis sputum on mucus-depleted bovine trachea
15. Physiotherapy for airway clearance in adults